financetom
Business
financetom
/
Business
/
Dollar Tree Q2 Earnings: Revenue And EPS Miss, Cuts Annual Forecasts As Customers Feel Macro Pressure On Spending, Stock Tumbles
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Dollar Tree Q2 Earnings: Revenue And EPS Miss, Cuts Annual Forecasts As Customers Feel Macro Pressure On Spending, Stock Tumbles
Sep 6, 2024 12:11 PM

Dollar Tree, Inc.'s ( DLTR ) stock is falling after the company reported worse-than-expected second-quarter 2024 earnings.

The discount variety stores chain reported an adjusted EPS of $0.67, missing the consensus of $1.04, and down 26.4% year over year.

Chief Financial Officer Jeff Davis added, "Our adjusted EPS of $0.67 was $0.38 below the midpoint of our previous outlook range. While the vast majority of this variance was attributable to an adjustment of our general liability accrual, a portion was attributable to a comp shortfall, which reflected the increasing effect of macro pressures on the purchasing behavior of Dollar Tree's ( DLTR ) middle- and higher-income customers."

Also Read: Walmart, Target Are Eating Dollar Stores' Lunch: Dollar General Lowers Guidance, Will Dollar Tree Be Next?

The company reported sales of $7.38 billion, up marginally by 0.07%, missing the consensus of $7.5 billion.

Dollar Tree ( DLTR ) reported same-store sales growth of 1.3%, the Family Dollar segment reported a marginal decline of 0.1%, and the Enterprise segment reported same-store sales growth of 0.7%.

During the second quarter, Dollar Tree ( DLTR ) initiated a formal review of strategic alternatives for the Family Dollar business segment, which could include a potential sale, spin-off, or other disposition of the business.

Guidance: The company is lowering its full-year fiscal 2024 consolidated net sales outlook range to $30.6 billion to $30.9 billion, down from prior guidance of $31 billion—$32 billion versus the consensus of $31.19 billion.

"We are updating our full-year outlook to reflect second-quarter results, including the general liability charge, a more conservative sales outlook at Dollar Tree ( DLTR ) for the balance of the year, and incremental start-up costs associated with the conversion of our recently acquired portfolio of 99 Cents Only Stores leases," Davis added.

The company expects to deliver comparable store net sales growth in the low-single-digits for the enterprise and both the Dollar Tree ( DLTR ) and Family Dollar segments.

Dollar Tree ( DLTR ) expects an adjusted diluted EPS of $5.20-$5.60 compared to prior guidance of $6.50-$7.00, versus the consensus of $6.56.

For the third quarter of 2024, Dollar Tree ( DLTR ) forecasts sales of $7.4 billion—$7.6 billion, compared to the consensus of $7.59 billion, based on comparable store net sales growth in the low single digits for the enterprise and both the Dollar Tree ( DLTR ) and Family Dollar segments.

Adjusted diluted EPS for the third quarter of 2024 is estimated to be $1.05-$1.15 compared to the consensus of $1.32.

Price Action: DLTR stock is down 11.8% at $72 during the premarket session at last check Wednesday.

Read Next:

EXCLUSIVE: Vivani Medical Reveals Positive Preclinical Liver Fat Results From Miniature GLP-1 Implant For Obesity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Halozyme Therapeutics Q3 Adjusted Earnings, Revenue Rise; 2025 Guidance Revised
Halozyme Therapeutics Q3 Adjusted Earnings, Revenue Rise; 2025 Guidance Revised
Nov 3, 2025
04:20 PM EST, 11/03/2025 (MT Newswires) -- Halozyme Therapeutics ( HALO ) reported Q3 adjusted earnings late Monday of $1.72 per diluted share, up from $1.27 a year earlier. Analysts polled by FactSet expected $1.63. Revenue for the three months ended Sept. 30 was $354.3 million, up from $290.1 million a year earlier. Analysts surveyed by FactSet expected $340 million....
Compression therapy provider Tactile Systems' Q3 revenue beats estimates
Compression therapy provider Tactile Systems' Q3 revenue beats estimates
Nov 3, 2025
Overview * Tactile Systems ( TCMD ) Q3 revenue rises 17% yr/yr, beating analyst expectations * Adjusted EBITDA for Q3 beats analyst estimates, showing operational efficiency * Company authorizes $25 mln share repurchase program, indicating financial confidence Outlook * Company expects 2025 revenue between $317 mln and $321 mln, up from prior $310 mln to $315 mln * Company raises...
Household products maker Clorox Q1 revenue beats analyst expectations
Household products maker Clorox Q1 revenue beats analyst expectations
Nov 3, 2025
Overview * Clorox fiscal Q1 revenue decreased 19% but beat analyst expectations * Adjusted EPS for fiscal Q1 beats consensus despite a 54% year-over-year decrease * Company's ERP transition led to lower shipments and sales decline Outlook * Clorox maintains FY 2026 net sales outlook to decline 6% to 10% * Clorox expects FY 2026 adjusted EPS to be $5.95...
Weight loss products maker Medifast Q3 revenue declines amid challenges in client acquisition
Weight loss products maker Medifast Q3 revenue declines amid challenges in client acquisition
Nov 3, 2025
Overview * Medifast ( MED ) Q3 revenue falls 36.2% yr/yr due to fewer active earning coaches * Company reports Q3 net loss of $2.3 mln, compared to net income last year * Medifast ( MED ) maintains strong balance sheet with $173.5 mln in cash, no debt Outlook * Company expects Q4 2025 revenue between $65 mln and $80...
Copyright 2023-2026 - www.financetom.com All Rights Reserved